Research workbench
Structure of human mait a-F7 TCR in complex with human MR1-JYM72
Analyse Structure of human mait a-F7 TCR in complex with human MR1-JYM72 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6PUK
- Type
- protein
- Length
- 1,613 residues
- Chains
- 8
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Major histocompatibility complex class I-related gene protein; Tra@ protein; Human TCR…
- UniProt
- Q95460, P61769
- Ligands
- OYV, NA
- Pockets
- 20 · best druggability 0.81
Structure
x-ray diffraction · 8 distinct chains · 12% helix, 46% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Major histocompatibility complex class I-related gene protein | protein | 266 | 27% helix, 40% strand | Q95460 |
| B | Tra@ protein | protein | 201 | 3% helix, 45% strand | — |
| C | Major histocompatibility complex class I-related gene protein | protein | 266 | 28% helix, 41% strand | Q95460 |
| D | Tra@ protein | protein | 196 | 3% helix, 47% strand | — |
| E | Human TCR beta chain | protein | 243 | 6% helix, 50% strand | — |
| F | Beta-2-microglobulin | protein | 99 | 0% helix, 52% strand | P61769 |
| G | Human TCR beta chain | protein | 244 | 7% helix, 49% strand | — |
| H | Beta-2-microglobulin | protein | 98 | 0% helix, 50% strand | P61769 |
Ligands and binding sites
- OYV · 1,2-dideoxy-1-{2,6-dioxo-5-[(1E)-3-oxobut-1-en-1-yl]-1, 2,3,6-tetrahydropyrimidin-4-yl}-D-ribo-hexitol · ligand · 2 copies · chains A, B, C, D
- NA · Sodium ion · metal · 3 copies · chains F, G, H
- GOL · Glycerol · additive · 3 copies · chains A, G, C, F
- ACT · Acetate ion · additive · chains F
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 12 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1053 | 0.81 | 0.82 | 98 | empty |
| 2 | 413 | 0.77 | 0.86 | 53 | OYV |
| 3 | 413 | 0.76 | 0.85 | 47 | OYV |
| 4 | 1049 | 0.71 | 0.75 | 90 | empty |
| 5 | 905 | 0.69 | 0.75 | 77 | empty |
Interfaces
12 interfaces between chains.
- B–G · 2073 Ų buried · 23 hydrogen bonds · protein-protein
- D–E · 1988 Ų buried · 23 hydrogen bonds · protein-protein
- C–F · 1289 Ų buried · 17 hydrogen bonds · protein-protein
- A–H · 1255 Ų buried · 17 hydrogen bonds · protein-protein
- C–G · 879 Ų buried · 8 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 16 disulfide, 2 covalent (disulfide, covalent ligand).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q95460
- Every structure of UniProt P61769
- Elsewhere: RCSB PDB 6PUK · PDBe 6PUK · UniProt Q95460 · UniProt P61769
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.